Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hextar Healthcare BhdXKLS:7803 -7.69% Net Cash per Share is RM-0.00 as of Jun. 2026. The stock has 3 warning signs investors should review. Among 297 Chemicals companies, Hextar Healthcare Bhd ranks worse than 336700% on this metric.
The historical rank and industry rank for Hextar Healthcare Bhd's Net Cash per Share or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Cash Ratio of Hextar Healthcare Bhd was 175.33. The lowest was 1.93. And the median was 8.71.
XKLS:7803's Price-to-Net-Cash is not ranked *
in the Chemicals industry.
Industry Median: 9.31 * Ranked among companies with meaningful Price-to-Net-Cash only.
Hextar Healthcare Bhd (XKLS:7803) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Hextar Healthcare Bhd Net Cash per Share Related Terms
Hextar Healthcare Bhd Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Hextar Healthcare Bhd's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7803 vs LIN, SHW, ECL: Net Cash per Share Comparison
For the Specialty Chemicals subindustry, Hextar Healthcare Bhd's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hextar Healthcare Bhd Price-to-Net-Cash vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Hextar Healthcare Bhd's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Hextar Healthcare Bhd's Price-to-Net-Cash falls into.
Hextar Healthcare Bhd Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Hextar Healthcare Bhd's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hextar Healthcare Bhd (XKLS:7803) has a Net Cash per Share of RM-0.00 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Hextar Healthcare Bhd and its competitors. According to the industry distribution chart, Hextar Healthcare Bhd ranks #999999 out of 297 companies in the Chemicals industry.
Is Hextar Healthcare Bhd's Net Cash per Share too high?
Hextar Healthcare Bhd's current Net Cash per Share is RM-0.00. Based on the distribution chart, Hextar Healthcare Bhd ranks #999999 out of 297 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Hextar Healthcare Bhd's Net Cash per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Hextar Healthcare Bhd ranks #999999 out of 297 companies for Net Cash per Share. This places Hextar Healthcare Bhd in the lower half of its industry. The industry median Net Cash per Share is 9.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Chemicals company?
The median Net Cash per Share among Chemicals companies is 9.31, based on 297 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Hextar Healthcare Bhd and its competitors. For the Chemicals industry, the median Net Cash per Share is 9.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hextar Healthcare Bhd's current Net Cash per Share is RM-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.13, compared to a current price of RM0.06 — trading 53.8% below its estimated fair value. The current Net Cash per Share is RM-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Net Cash per Share is RM-0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hextar Healthcare Bhd is a Malaysian investment holding company whose subsidiaries manufacture and sell rubber and synthetic gloves. Its product range includes industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile examination gloves, serving customers in the healthcare, industrial, food handling, and consumer markets. The company operates through three reporting segments: gloves operations, medical devices operations, and investment holding, with the gloves segment generating the majority of revenue. Manufacturing is based in Malaysia, and its products are exported internationally, with sales across Europe, Asia, North and South America, and other regions. Revenue is derived primarily from the manufacture and sale of gloves to distributors, healthcare suppliers, and industrial buyers worldwide. The company was formerly known as Rubberex Corporation (M) Bhd before adopting the Hextar Healthcare name following its acquisition by the Hextar group.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7803 has been successfully added to your 
